MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Durect Corp

Fechado

1.92

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.92

Máximo

1.92

Indicadores-chave

By Trading Economics

Funcionários

13

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+30.89% upside

Dividendos

By Dow Jones

Próximos Ganhos

12 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

326K

51M

Abertura anterior

1.92

Fecho anterior

1.92

Durect Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de out. de 2025, 18:13 UTC

Grandes Movimentos do Mercado

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 de out. de 2025, 17:05 UTC

Grandes Movimentos do Mercado

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17 de out. de 2025, 15:03 UTC

Grandes Movimentos do Mercado

Obook Shares Sink Following Public Debut

17 de out. de 2025, 14:41 UTC

Grandes Movimentos do Mercado

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17 de out. de 2025, 23:25 UTC

Aquisições, Fusões, Aquisições de Empresas

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 de out. de 2025, 22:15 UTC

Conversa de Mercado

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 de out. de 2025, 21:15 UTC

Conversa de Mercado

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 de out. de 2025, 21:07 UTC

Conversa de Mercado

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 de out. de 2025, 21:07 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

17 de out. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de out. de 2025, 20:34 UTC

Conversa de Mercado

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 de out. de 2025, 20:27 UTC

Conversa de Mercado

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 de out. de 2025, 19:46 UTC

Conversa de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 de out. de 2025, 19:45 UTC

Conversa de Mercado

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 de out. de 2025, 18:45 UTC

Conversa de Mercado

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 de out. de 2025, 17:51 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de out. de 2025, 17:51 UTC

Conversa de Mercado

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 de out. de 2025, 17:44 UTC

Conversa de Mercado

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 de out. de 2025, 17:35 UTC

Conversa de Mercado

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 de out. de 2025, 16:20 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

17 de out. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de out. de 2025, 16:14 UTC

Conversa de Mercado

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 de out. de 2025, 16:04 UTC

Conversa de Mercado

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 de out. de 2025, 15:58 UTC

Conversa de Mercado

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 de out. de 2025, 15:56 UTC

Ganhos

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 de out. de 2025, 15:43 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

17 de out. de 2025, 15:43 UTC

Conversa de Mercado

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17 de out. de 2025, 14:58 UTC

Conversa de Mercado

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17 de out. de 2025, 14:41 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de out. de 2025, 14:35 UTC

Conversa de Mercado
Ganhos

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Comparação entre Pares

Variação de preço

Durect Corp Previsão

Preço-alvo

By TipRanks

30.89% parte superior

Previsão para 12 meses

Média 2.5 USD  30.89%

Máximo 2.5 USD

Mínimo 2.5 USD

Com base em 1 analistas de Wall Street que oferecem metas de preço de 12 meses para Durect Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

1 ratings

0

Comprar

1

Manter

0

Vender

Informação Financeira

$

Sobre Durect Corp

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
help-icon Live chat